丁酸梭菌市場規模、佔有率和成長分析：按產品等級、製劑類型、目標應用、最終用戶和地區分類 - 產業預測，2026-2033年

2024 年全球丁酸梭菌市場價值為 15 億美元，預計到 2025 年將成長至 16.2 億美元，到 2033 年將成長至 30 億美元，在預測期（2026-2033 年）內複合年成長率為 8.0%。

全球丁酸梭菌市場圍繞著對人類和動物健康、食品保藏和工業發酵至關重要的產孢益生菌。這些菌株以其改善腸道健康、產生抗菌肽和合成丁酸的能力而聞名，這些特性是產品功效的基礎，也是獲得監管部門核准的關鍵。從利基研究到廣泛商業化的轉變反映了培養、封裝和物流技術的進步，尤其是在生產者尋求有效抗生素替代品的情況下。這種對替代品日益成長的需求正在透過減少腸道感染疾病、提高畜牧業生產力和降低成本來推動市場成長。此外，有關腸道疾病益處的臨床證據正在促進夥伴關係和創新。人工智慧在產品開發中的應用正在加速發現、提高品質、實現產品差異化並加強供應鏈。

丁酸梭菌的全球市場促進因素

消費者對益生菌益處的認知不斷提高，以及對腸道健康的日益關注，正顯著推動丁酸梭菌的全球市場成長。隨著醫療保健專業人士和營養學家推薦旨在改善消化功能和增強免疫反應的標靶微生物組療法，對丁酸梭菌等特定菌株的需求正爆炸式成長。教育宣傳的加強和媒體曝光的增加進一步推動了這一趨勢，提高了消費者對這類產品的接受度，並減少了他們的疑慮。因此，消費者接受度的提高促使製造商加大對整個供應鏈產能和創新方面的投資，從而拓展了膳食補充劑和機能性食品的產品線。

全球丁酸梭菌市場限制因素

由於益生菌菌株法規結構不一致且安全評估通訊協定嚴格，全球丁酸梭菌市場面臨許多挑戰。這些區域性標準差異導致丁酸梭菌產品的分類、標籤和核准用途複雜化，進而延長了核准時間，並增加了尋求核准的生產商的行政負擔。這種監管複雜性阻礙了中小企業進行產品研發，並延緩了新產品上市。因此，現有企業往往優先考慮合規而非創新，從而限制了整體市場的成長和擴張潛力。

丁酸梭菌的全球市場趨勢

全球丁酸梭菌市場呈現顯著成長趨勢，主要受醫療保健領域對益生菌需求不斷成長的推動。隨著消費者日益重視腸道健康和免疫支持，丁酸梭菌正成為益生菌菌株中的佼佼者。相關人員強調，為了吸引醫療保健專業人員和注重健康的消費者，必須建立嚴謹的證據體系，確保製劑穩定性，並開發創新的給藥形式。生技公司與臨床研究人員之間的合作正在拓展產品線，並提升專業信譽。這一趨勢有助於制定精準的行銷策略，支持以臨床數據為依據的療效聲明，並加大對檢驗治療應用的投入，同時促進監管合規和臨床應用，從而增強產品差異化和信譽度。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球丁酸梭菌市場規模：依產品等級分類

• 醫藥級
• 食品級
• 飼料級

全球丁酸梭菌市場規模：依製劑類型分類

• 粉末/顆粒
• 膠囊和片劑
• 發酵醪液

全球丁酸梭菌市場規模：依應用領域分類

• 人體消化器官系統健康
• 家禽飼料添加劑
• 水產養殖中的健康管理
• 豬和反芻動物的營養

全球丁酸梭菌市場規模：依最終用戶分類

• 製藥公司
• 食品和飲料製造商
• 畜牧業和農業

全球丁酸梭菌市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要企業2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要企業的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要企業簡介

• Miyarisan Pharmaceutical
• Zhejiang Biorun Biotech
• Scitop Biomaterials
• Hangzhou Fuli Biotech
• Guangdong Yuewei Biotech
• Shanghai Sinehealth
• Wuhan Yuancheng
• Hefei Originwater
• Chongqing Yunstar
• Hubei Jiuding
• AOR Canada
• Mitushi Bio Pharma
• Hangzhou Vega
• Sunhy Group
• Kemin Industries
• Novozymes
• Lallemand Health
• ADM
• Chr. Hansen
• DuPont

結論與建議

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球丁酸梭菌市場規模：依產品等級分類

• 醫藥級
• 食品級
• 飼料級

全球丁酸梭菌市場規模：依製劑類型分類

• 粉末/顆粒
• 膠囊和片劑
• 發酵醪液

全球丁酸梭菌市場規模：依應用領域分類

• 人體消化器官系統健康
• 家禽飼料添加劑
• 水產養殖中的健康管理
• 豬和反芻動物的營養

全球丁酸梭菌市場規模：依最終用戶分類

• 製藥公司
• 食品和飲料製造商
• 畜牧業和農業

全球丁酸梭菌市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要企業2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要企業的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要企業簡介

• Miyarisan Pharmaceutical
• Zhejiang Biorun Biotech
• Scitop Biomaterials
• Hangzhou Fuli Biotech
• Guangdong Yuewei Biotech
• Shanghai Sinehealth
• Wuhan Yuancheng
• Hefei Originwater
• Chongqing Yunstar
• Hubei Jiuding
• AOR Canada
• Mitushi Bio Pharma
• Hangzhou Vega
• Sunhy Group
• Kemin Industries
• Novozymes
• Lallemand Health
• ADM
• Chr. Hansen
• DuPont

結論與建議

Global Clostridium Butyricum Market size was valued at USD 1.5 Billion in 2024 and is poised to grow from USD 1.62 Billion in 2025 to USD 3.0 Billion by 2033, growing at a CAGR of 8.0% during the forecast period (2026-2033).

The global market for Clostridium butyricum revolves around a spore-forming probiotic bacterium crucial for human and animal health, food preservation, and industrial fermentation. Its strains are known for gut-modulating effects, antimicrobial peptide production, and butyrate synthesis, which support product claims and spur regulatory approvals. The transition from niche research to widespread commercialization reflects advances in cultivation, encapsulation, and logistics, particularly as producers seek effective antibiotic alternatives. The rising demand for these substitutes enhances market growth by decreasing enteric infections and improving livestock performance while reducing costs. Additionally, clinical evidence of benefits for gut disorders fosters partnerships and innovation. The integration of AI in product development accelerates discovery and enhances quality, thereby differentiating offerings and strengthening supply chains.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Clostridium Butyricum market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Clostridium Butyricum Market Segments Analysis

Global clostridium butyricum market is segmented by product grade, formulation type, target application, end-user and region. Based on product grade, the market is segmented into Pharma Grade, Food Grade and Feed Grade. Based on formulation type, the market is segmented into Powder/Granules, Capsules & Tablets and Liquid Fermentation Broth. Based on target application, the market is segmented into Human Digestive Health, Poultry Feed Additives, Aquaculture Health Management and Swine & Ruminant Nutrition. Based on end-user, the market is segmented into Pharmaceutical Companies, Food & Beverage Manufacturers and Animal Husbandry & Farming. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Clostridium Butyricum Market

The global market for Clostridium butyricum is being significantly propelled by an increase in consumer awareness regarding the advantages of probiotics and a heightened focus on gut health. As healthcare professionals and nutritionists advocate for targeted microbial therapies to enhance digestion and bolster immune responses, there has been a marked rise in demand for specialized strains like Clostridium butyricum. This trend is further supported by enhanced educational initiatives and media exposure, which have fostered greater consumer acceptance and diminished skepticism surrounding these products. Consequently, this growing acceptance encourages manufacturers to invest in production capabilities and innovation across the entire supply chain, expanding their offerings in supplements and functional foods.

Restraints in the Global Clostridium Butyricum Market

The Global Clostridium Butyricum market faces significant challenges due to inconsistent regulatory frameworks and stringent safety assessment protocols for probiotic strains. These varying standards across different regions complicate the classification, labeling, and approved applications of Clostridium butyricum products, resulting in prolonged timelines and increased administrative burdens for manufacturers seeking approvals. This regulatory complexity can deter smaller companies from engaging in product development, slowing down the introduction of new products into the market. Consequently, established firms often redirect their resources toward maintaining compliance rather than fostering innovation, thereby restricting the overall growth and expansion potential of the market.

Market Trends of the Global Clostridium Butyricum Market

The Global Clostridium Butyricum market is witnessing a notable trend driven by the growing demand for probiotics in healthcare. As consumers increasingly prioritize gut health and immune support, Clostridium butyricum is emerging as a leading choice among probiotic strains. Industry stakeholders are emphasizing the importance of rigorous evidence generation, stability in formulations, and innovative delivery formats to appeal to both medical professionals and wellness-focused consumers. Collaborative efforts between biotech firms and clinical researchers are expanding product offerings and fostering professional credibility. This trend promotes targeted marketing strategies, clinically substantiated claims, and significant investments in validated therapeutic applications, enhancing product differentiation and trust while facilitating regulatory compliance and clinical adoption.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Clostridium Butyricum Market Size by Product Grade & CAGR (2026-2033)

• Market Overview
• Pharma Grade
• Food Grade
• Feed Grade

Global Clostridium Butyricum Market Size by Formulation Type & CAGR (2026-2033)

• Market Overview
• Powder/Granules
• Capsules & Tablets
• Liquid Fermentation Broth

Global Clostridium Butyricum Market Size by Target Application & CAGR (2026-2033)

• Market Overview
• Human Digestive Health
• Poultry Feed Additives
• Aquaculture Health Management
• Swine & Ruminant Nutrition

Global Clostridium Butyricum Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical Companies
• Food & Beverage Manufacturers
• Animal Husbandry & Farming

Global Clostridium Butyricum Market Size & CAGR (2026-2033)

• North America (Product Grade, Formulation Type, Target Application, End-User)
  • US
  • Canada
• Europe (Product Grade, Formulation Type, Target Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Grade, Formulation Type, Target Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Grade, Formulation Type, Target Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Grade, Formulation Type, Target Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Miyarisan Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Biorun Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scitop Biomaterials
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hangzhou Fuli Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guangdong Yuewei Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai Sinehealth
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuhan Yuancheng
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hefei Originwater
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chongqing Yunstar
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hubei Jiuding
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AOR Canada
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitushi Bio Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hangzhou Vega
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sunhy Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kemin Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novozymes
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lallemand Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADM
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chr. Hansen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DuPont
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations